Progress of hyperventilation syndrome in children / 国际儿科学杂志

Hyperventilation syndrome(HVS)in children is a common functional respiratory disorder with a group of symptoms mainly characterized by hyperventilation, which is usually triggered by anxiety or stress events.A standardized questionnaire and the hyperventilation provocation test are helpful for diagnosis.Currently, the Nijmegen questionnaire is a common clinical tool to quantify and assess the severity of the symptoms.Emotional and psychological factors are major causes of HVS onset, meanwhile, abnormal breathing patterns are also implicated.Reassurance therapy and breathing retraining can improve the symptoms.

The Relationship Of Social Distrust With Personal Suffering: Mediating Capacity Of Excessive Reassurance Seeking

This study investigated the relationship between Social Distrust (SD) with Personal Suffering (PS). This paper considered Excessive Reassurance Seeking (ERS) as a social method of expressing one’s lack of trust on others. Methods: Analytical technique of linear regression was used to test the relations statistically. A sampling method of convenient and referral selection was applied to select 85 respondents from the city of Faisalabad, Pakistan. Results: Analysis showed that only ERS predicted PS significantly (B = 0.623, p < 0.001). Age also decreased ERS in the sample (B = -0.208, p < 0.01). Conclusion: Age reduced ERS because elders became more focused on their personal objectives and therefore, they did not feel the need to confirm loyal attachment of others. Additionally, ERS contributes to increase PS as people confirm sincerity of their social circle regularly. Friends and family do not withstand constant scrutiny of their motives and individuals who use ERS intensively experience depressing loneliness in the society. ASEAN Journal of Psychiatry, Vol. 18 (1): January – June 2017: XX XX.

Regurgitation and Gastroesophageal Reflux Disease in Six to Nine Months Old Indonesian Infants / 대한소아소화기영양학회지

PURPOSE: Regurgitation is known to peak at the age of 3-4 months, with a sharp decrease around the age of 6 months. Little is known about the natural evolution of infants who still regurgitate after the age of 6 months. METHODS: Hundred thirty-one infants older than 6 months regurgitating more than once a day were followed for a period of 3 months. RESULTS: According to our data, gastroesophageal reflux disease (GERD) is seldom at this age. Most of the infants regurgitated 3 or more times/day and spit up an estimated volume of more than 15 mL. Eighty-five parents were educated regarding frequency of feeding. There were only 6 infants that still had frequent regurgitation (>3 times/day) despite an appropriate feeding schedule. The Infant GER Questionnaire score reached a score of 0 in 50% of the infants after one month of follow-up and in 81.9% at the third month of follow-up. There was an increase of the "weight for age z-score" trends in infants that still regurgitated at the end of follow-up and a declining z-score in infants that no longer regurgitated. An explanation may be that infants that regurgitate drink larger volumes than infants who do not regurgitate. Conservative treatment (reassurance, dietary treatment, behavioral advice) resulted in a significant better outcome than natural evolution. CONCLUSION: Regurgitation that persisted after the age of 6 months, strongly decreased during a 3-month follow-up with conservative treatment. GERD is rare in this age group; therefore, anti-reflux medication is only seldom needed.

Clonazepam Treatment of Pathologic Childhood Aerophagia with Psychological Stresses

The treatment of pathologic aerophagia has rarely been discussed in the literature. In this retrospective study, the authors investigated the effects of clonazepam on the management of pathologic childhood aerophagia (PCA) with psychological stresses (PS), but not with mental retardation. Data from 22 consecutive PCA patients with PS (aged 2 to 10 yr), who had been followed up for over 1 yr, were reviewed. On the basis of videolaryngoscopic views, the authors observed that the pathology of aerophagia was the result of reflex-induced swallowing with paroxysmal openings of the upper esophageal sphincter due to unknown factors and also observed that these reflex-induced openings were subsided after intravenous low dose benzodiazepine administration. Hence, clonazepam was administered to treat paroxysmal openings in these PCA patients with PS. Remission positivity was defined as symptom-free for a consecutive 1 month within 6 months of treatment. The results of treatment in 22 PCA patients with PS were analyzed. A remission positive state was documented in 14.3% of PCA patients managed by reassurance, and in 66.7% of PCA patients treated with clonazepam (p=0.032). Thus, clonazepam may produce positive results in PCA with PS. Future studies by randomized and placebo-controlled trials are needed to confirm the favorable effect of clonazepam in PCA.